Anaphylaxis: Difference between revisions

no edit summary
No edit summary
No edit summary
Line 58: Line 58:


[https://pubmed.ncbi.nlm.nih.gov/37172716/ Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis]
[https://pubmed.ncbi.nlm.nih.gov/37172716/ Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis]
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403119/ Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-]